The PDF brochure for the Biosimilars Market Access & Commercialization Executive Boardroom is now available. Download it now

Featured Speakers

Top Reasons to Attend:

  • Examine the first wave of approved and marketed biosimilars and discover trends for successful commercialization
  • Participate in an intensive workshop on Educating External Stakeholders, such as Payers, Patients, and Physicians on the Benefit and Opportunity of Biosimilars
  • Hear firsthand from industry leaders as they shed light on turning obstacles into opportunities, including challenges around regulatory uncertainty and caution on the part of policy makers, payers, and physicians, hindering the growth of the biosimilars market
  • Insight into the preparation of your biosimilar playbook highlighting strategic and operational capabilities necessary to achieve compete advantage
  • Best practice insight on successful biosimilar commercialization strategies from Merck, Bayer, Medimmune and Pfizer

Deep Dive and Get into the Weeds with our Hands-on Workshop

  • Develop a Biosimilars Education Plan, Educating External Stakeholders, Such as Payers, Patients and Physicians on the Benefit and Opportunity of Biosimilars